An 8-year-old male with 4 days of fever, abdominal pain, and jaundice.
1University of Utah, Department of Pediatrics, Salt Lake City, UT, USA.
Leah Faye
LF
Farley
Laura Nell
LN
Hodo
D015746:Abdominal Pain / Q000188:drug therapy / Q000209:etiology*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002443:Ceftriaxone / Q000627:therapeutic use; D002648:Child; D002981:Clindamycin / Q000627:therapeutic use; D003231:Conjunctivitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D003937:Diagnosis, Differential; D005334:Fever / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D000069285:Infliximab; D007565:Jaundice / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D009254:Nafcillin / Q000627:therapeutic use; D012772:Shock, Septic / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D012965:Sodium Chloride / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D002981:Clindamycin; D012965:Sodium Chloride; D009254:Nafcillin; D002443:Ceftriaxone; D000069285:Infliximab; D008775:Methylprednisolone